Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial
- DOI
- 10.4093/dmj.2023.0077
- Published
- 2024-07-31
- Container
- Diabetes & Metabolism Journal
- Publisher
- Korean Diabetes Association
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.4093/dmj.2023.0077,
title = {Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial},
author = {Jie-Eun Lee and Seung Hee Yu and Sung Rae Kim and Kyu Jeung Ahn and Kee-Ho Song and In-Kyu Lee and Ho-Sang Shon and In Joo Kim and Soo Lim and Doo-Man Kim and Choon Hee Chung and Won-Young Lee and Soon Hee Lee and Dong Joon Kim and Sung-Rae Cho and Chang Hee Jung and Hyun Jeong Jeon and Seung-Hwan Lee and Keun-Young Park and Sang Youl Rhee and Sin Gon Kim and Seok O Park and Dae Jung Kim and Byung Joon Kim and Sang Ah Lee and Yong-Hyun Kim and Kyung-Soo Kim and Ji A Seo and Il Seong Nam-Goong and Chang Won Lee and Duk Kyu Kim and Sang Wook Kim and Chung Gu Cho and Jung Han Kim and Yeo-Joo Kim and Jae-Myung Yoo and Kyung Wan Min and Moon-Kyu Lee},
year = {2024},
journal = {Diabetes \& Metabolism Journal},
doi = {10.4093/dmj.2023.0077},
url = {https://doi.org/10.4093/dmj.2023.0077}
}RIS
TY - JOUR TI - Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial AU - Jie-Eun Lee AU - Seung Hee Yu AU - Sung Rae Kim AU - Kyu Jeung Ahn AU - Kee-Ho Song AU - In-Kyu Lee AU - Ho-Sang Shon AU - In Joo Kim AU - Soo Lim AU - Doo-Man Kim AU - Choon Hee Chung AU - Won-Young Lee AU - Soon Hee Lee AU - Dong Joon Kim AU - Sung-Rae Cho AU - Chang Hee Jung AU - Hyun Jeong Jeon AU - Seung-Hwan Lee AU - Keun-Young Park AU - Sang Youl Rhee AU - Sin Gon Kim AU - Seok O Park AU - Dae Jung Kim AU - Byung Joon Kim AU - Sang Ah Lee AU - Yong-Hyun Kim AU - Kyung-Soo Kim AU - Ji A Seo AU - Il Seong Nam-Goong AU - Chang Won Lee AU - Duk Kyu Kim AU - Sang Wook Kim AU - Chung Gu Cho AU - Jung Han Kim AU - Yeo-Joo Kim AU - Jae-Myung Yoo AU - Kyung Wan Min AU - Moon-Kyu Lee PY - 2024 JO - Diabetes & Metabolism Journal DO - 10.4093/dmj.2023.0077 UR - https://doi.org/10.4093/dmj.2023.0077 ER -
APA
Lee, J., Yu, S. H., Kim, S. R., Ahn, K. J., Song, K., Lee, I., Shon, H., Kim, I. J., Lim, S., Kim, D., Chung, C. H., Lee, W., Lee, S. H., Kim, D. J., Cho, S., Jung, C. H., Jeon, H. J., Lee, S., Park, K., Rhee, S. Y., Kim, S. G., Park, S. O., Kim, D. J., Kim, B. J., Lee, S. A., Kim, Y., Kim, K., Seo, J. A., Nam-Goong, I. S., Lee, C. W., Kim, D. K., Kim, S. W., Cho, C. G., Kim, J. H., Kim, Y., Yoo, J., Min, K. W., & Lee, M. (2024). Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2023.0077
Source records
- crossref · retrieved 2026-09-26T15:34:47.751Z